Filter
40
Filtered Results: 40
Text search:
Pfizer-
BioNTech
Comirnaty
Vaccine
Featured
Recommendations
7
Language
Document type
Guidelines
19
Fact sheets
10
Studies & Reports
5
Online Courses
3
Manuals
2
Strategic & Response Plan
1
Countries / Regions
Brazil
5
Ukraine
4
Russia
4
China
3
Germany
3
Middle East and North Africa
3
Mozambique
2
Argentina
2
Ecuador
2
Kazakhstan
1
Global
1
Western and Central Europe
1
Paraguay
1
Belarus
1
South Africa
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
COVID-19
18
Guidelines
9
Capacity Building
3
x MEDBOX Issue Brief & Annual Reports x
1
Vaccine-preventable Diseases
1
Policies
1
Women & Child Health
1
Information, Education and Communication (IEC)
1
Studies & Reports
1
Humanitarian Crisis
1
Pharmacy & Technologies
1
Toolboxes
Biontech/Pfizer Comirnaty
16
Country specific documents
9
Immunization Guidelines
6
Logistics & Supply
5
Access & Strategy
4
COVID-19 Vaccination
4
Online Courses & Resources
3
For Health Worker
3
COVID-19 Vaccination Information
3
mRna Vaccines general
3
Booster Doses
3
Communication Material
2
SARS-CoV-2 Variants
2
Vaccination
1
Pediatrics
1
Anamnesis / Screening
1
Infection Control General
1
For General Public & Community
1
For Parents & Children
1
Vaccination & Strategy
1
Videos
1
Vaccine Candidates & Research
1
Dashboards & Resource Platforms
1
Long COVID/ Post-COVID Syndrome
1
Moderna
1
Vector-based Vacines General
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
Research & Pipeline
1
Inactivated COVID-19 Vaccines
1
Essential Medicines
1
Prices and Patents
1
Situation Reports & Updates
1
Global Overview
1
Human Rights & the Right to Health
1
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at...
Vaccine handling, storage and Transportation of Pfizer BioNTech
COVID-19 COMIRNATY® (Tozinameran)
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
updated version: 04/10/2021
Information about vaccine administration
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
(Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та Spikevax® виробництва Moderna);
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. ...
Health workers involved in deployment and implementation of COVID-19 vaccination require vaccine-specific knowledge to ensure safe and efficient vaccine delivery. This training provides key information about COVID-19 vaccines through short instructional videos, vaccine explainers, job aids, topic br...
Временное руководство, Первый выпуск 8 января 2021 г., Обновлено 15 июня 2021 г., Обновлено 19 ноября 2021 г.
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
Stand 21. Dezember 2021
